These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

746 related items for PubMed ID: 29154109

  • 1. Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma.
    Liu C, Lu Y, Sun H, Yang J, Liu Y, Lai X, Gong Y, Liu X, Li Y, Zhang Y, Chen X, Zhong D.
    J Pharm Biomed Anal; 2018 Feb 05; 149():394-402. PubMed ID: 29154109
    [Abstract] [Full Text] [Related]

  • 2. HPLC-MS/MS method for the simultaneous determination of clopidogrel, its carboxylic acid metabolite and derivatized isomers of thiol metabolite in clinical samples.
    Karaźniewicz-Łada M, Danielak D, Teżyk A, Zaba C, Tuffal G, Główka F.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec 12; 911():105-12. PubMed ID: 23217313
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing.
    Liu C, Zhang Y, Chen W, Lu Y, Li W, Liu Y, Lai X, Gong Y, Liu X, Li Y, Chen X, Li X, Sun H, Yang J, Zhong D.
    Eur J Pharm Sci; 2019 Jan 15; 127():151-160. PubMed ID: 30326264
    [Abstract] [Full Text] [Related]

  • 4. Development and validation of a UPLC-MS/MS method for simultaneous determination of vicagrel and its major metabolites in rat or human plasma: An optimized novel strategy for the stabilization of vicagrel.
    Tai T, Zhou H, Zhu T, Jia YM, Ji JZ, Li YF, Mi QY, Xie HG.
    J Pharm Biomed Anal; 2020 Feb 05; 179():112955. PubMed ID: 31866139
    [Abstract] [Full Text] [Related]

  • 5. Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS.
    Takahashi M, Pang H, Kawabata K, Farid NA, Kurihara A.
    J Pharm Biomed Anal; 2008 Dec 01; 48(4):1219-24. PubMed ID: 18829199
    [Abstract] [Full Text] [Related]

  • 6. A validated HPLC-MS/MS assay for quantifying unstable pharmacologically active metabolites of clopidogrel in human plasma: application to a clinical pharmacokinetic study.
    Furlong MT, Savant I, Yuan M, Scott L, Mylott W, Mariannino T, Kadiyala P, Roongta V, Arnold ME.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May 01; 926():36-41. PubMed ID: 23542721
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of vicagrel, a promising analog of clopidogrel, in rats and beagle dogs.
    Qiu Z, Li N, Wang X, Tian F, Liu Q, Song L, Fan Z, Lu Y, Chen X.
    J Pharm Sci; 2013 Feb 01; 102(2):741-9. PubMed ID: 23192851
    [Abstract] [Full Text] [Related]

  • 8. Development and validation of high-throughput liquid chromatography-tandem mass spectrometric method for simultaneous quantification of clopidogrel and its metabolite in human plasma.
    Reddy S R, Rao Divi K, Chandiran IS, Jayaveera KN, Naidu YK, Reddy MP.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb 01; 878(3-4):502-8. PubMed ID: 20060791
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A sensitive and rapid ultra HPLC-MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma.
    Peer CJ, Spencer SD, VanDenBerg DA, Pacanowski MA, Horenstein RB, Figg WD.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan 01; 880(1):132-9. PubMed ID: 22169056
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Significant Improvement of Metabolic Characteristics and Bioactivities of Clopidogrel and Analogs by Selective Deuteration.
    Xu X, Zhao X, Yang Z, Wang H, Meng X, Su C, Liu M, Fawcett JP, Yang Y, Gu J.
    Molecules; 2016 May 30; 21(6):. PubMed ID: 27248988
    [Abstract] [Full Text] [Related]

  • 13. The validation of a bioanalytical method for the determination of clopidogrel in human plasma.
    Robinson A, Hillis J, Neal C, Leary AC.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr 01; 848(2):344-54. PubMed ID: 17141580
    [Abstract] [Full Text] [Related]

  • 14. Overcoming the stability, solubility and extraction challenges in reversed-phase UHPLC-MS/MS bioanalysis of a phosphate drug and its prodrug in blood lysate.
    Yuan L, Basdeo S, Ji QC.
    J Pharm Biomed Anal; 2018 Aug 05; 157():36-43. PubMed ID: 29758468
    [Abstract] [Full Text] [Related]

  • 15. A validated enantioselective LC-MS/MS assay for the simultaneous determination of carvedilol and its pharmacologically active 4'-hydroxyphenyl metabolite in human plasma: application to a clinical pharmacokinetic study.
    Furlong MT, He B, Mylott W, Zhao S, Mariannino T, Shen J, Stouffer B.
    J Pharm Biomed Anal; 2012 Nov 05; 70():574-9. PubMed ID: 22709607
    [Abstract] [Full Text] [Related]

  • 16. Determination of clopidogrel metabolite (SR26334) in human plasma by LC-MS.
    Ksycinska H, Rudzki P, Bukowska-Kiliszek M.
    J Pharm Biomed Anal; 2006 May 03; 41(2):533-9. PubMed ID: 16406450
    [Abstract] [Full Text] [Related]

  • 17. An improved method for specific and quantitative determination of the clopidogrel active metabolite isomers in human plasma.
    Tuffal G, Roy S, Lavisse M, Brasseur D, Schofield J, Delesque Touchard N, Savi P, Bremond N, Rouchon MC, Hurbin F, Sultan E.
    Thromb Haemost; 2011 Apr 03; 105(4):696-705. PubMed ID: 21301779
    [Abstract] [Full Text] [Related]

  • 18. Rapid determination of canagliflozin in rat plasma by UHPLC-MS/MS using negative ionization mode to avoid adduct-ions formation.
    Iqbal M, Ezzeldin E, Al-Rashood KA, Asiri YA, Rezk NL.
    Talanta; 2015 Jan 03; 132():29-36. PubMed ID: 25476275
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: Application to a bioequivalence study.
    Rezk MR, Basalious EB, Karim IA.
    J Pharm Biomed Anal; 2015 Oct 10; 114():97-104. PubMed ID: 26037157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.